ACM
CGEM icon

Aquatic Capital Management’s Cullinan Oncology CGEM Stock Holding History

Aquatic Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,923
Closed -$320K – 1428
2025
Q4 		$320K Buy
30,923
+28,141
+1,012% +$254K 0.01% 871
2025
Q3 		$16.5K Buy
+2,782
New +$20.4K ﹤0.01% 1322
2025
Q2 		– Sell
-395
Closed -$2.99K – 1273
2025
Q1 		$2.99K Sell
395
-5,962
-94% -$57.2K ﹤0.01% 1203
2024
Q4 		$77.4K Buy
+6,357
New +$91.4K ﹤0.01% 1109
2023
Q1 		– Sell
-7,200
Closed -$75K – 1316
2022
Q4 		$75K Buy
+7,200
New +$87.5K 0.01% 927

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Aquatic Capital Management's CGEM Position: Q1 2026 in Review

Aquatic Capital Management sold out of Cullinan Oncology (CGEM) in Q1 2026, closing a stake of 30,923 shares — an estimated $320K sold.

Aquatic Capital Management first reported a position in CGEM in Q4 2022 and held it in 5 quarters. The position peaked at $320K in Q4 2025. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Aquatic Capital Management reported no remaining Cullinan Oncology position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 30,923 Cullinan Oncology shares in Q1 2026, an estimated $320K.
  • Aquatic Capital Management first reported a position in Cullinan Oncology in Q4 2022 and held it in 5 quarters.
  • Aquatic Capital Management's Cullinan Oncology position peaked at $320K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.